Human SSTR2 VLP Protein
Catalog No: SSTR2-HP001
- Species
- Human
- Expression System
- HEK293
Product overview
Human SSTR2 VLP Protein is a full-length multi-pass membrane protein presented in a VLP format for antibody discovery, binding assays and method development. Recombinant Human SSTR2 VLP is expressed from HEK293. It contains Met1-Ile369 (It may have cross reaction with anti-His antibody) (accession: P30874-1).
Product Details
- Molecular Aliases
- SS-2-R; SS2-R; SS2R; SRIF-1; SRIF1; SRIF 1; Smstr2; SST2; SSTR2
- Protein Length
- Met1-Ile369
- Expression System
- HEK293
- Theoretical Molecular Weight
- The target protein has a predicted MW of 42.7 kDa.
- Purity
- > 95% as determined by HPLC
- Endotoxin
- Less than 1 EU per μg by the LAL method.
- Buffer / Formulation
- Supplied as 0.22μm filtered solution in PBS, 300mM L-arginine (pH 7.4). Notice: If you need it for immunization, water-soluble adjuvant is recommended.
- State
- Liquid
- Storage Conditions
- Valid for 12 months from date of receipt when stored at -80°C. Aliquot where appropriate and minimize freeze-thaw cycles.
Background
Somatostatin receptor (SSTR) 2, widely expressed in meningioma, is a G-protein-coupled receptor and can be activated by somatostatin or its synthetic analogs. SSTR2 is therefore extensively studied as a marker and target for the diagnosis and treatment of meningioma.
References
- Wu W, Zhou Y, Wang Y, Liu L, Lou J, Deng Y, Zhao P, Shao A. Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma. Front Oncol. 2020 Sep 3;10:1633. doi: 10.3389/fonc.2020.01633. PMID: 33014821; PMCID: PMC7494964.
Have questions about this product?
Our technical team can help with product selection, application questions and order support.